Correction (DOI:10.1016/j.jaci.2006.07.035);First case of homozygous C1 inhibitor deficiency

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 6, 2006, Pages 1330-1335

  Blanch, Alvaro ^a   Roche, Olga ^a   Urrutia, Ignacio ^b   Gamboa, Pedro ^b   Fontán, Gumersindo ^a   López Trascasa, Margarita ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

Author keywords

C1 inhibitor; classical complement activation pathway; Hereditary angioedema; homozygous C1NH mutation; serine protease inhibitor

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR;

ADOLESCENT; ADULT; AGED; ALLELE; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT COMPONENT C 1 INHIBITOR DEFICIENCY; COMPLEMENT DEFICIENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LONG TERM CARE; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WILD TYPE;

EID: 33845213198     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.02.001     Document Type: Erratum

References (20)

1. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the Third C1 Esterase Inhibitor Deficiency Workshop and beyond. J Allergy Clin Immunol 114 suppl (2004) S51-S131
2. Agostoni A., and Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 71 (1992) 206-215
3. Roche O., Blanch A., Caballero T., Sastre N., Callejo D., and López-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 94 (2005) 498-503
4. Bork K., Siedlecki K., Bosch S., Schopf R.E., and Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 75 (2000) 349-354
5. Bork K., Hardt J., Schicketanz K.H., and Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 163 (2003) 1229-1235
6. Rosen F.S., Pensky J., Donaldson V., and Charache P. Hereditary angioneurotic edema: two genetic variants. Science 148 (1965) 957-958
7. Rosen F.S., Alper C.A., Pensky J., Klemperer M.R., and Donaldson V.H. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 50 (1971) 2143-2149
8. Verpy E., Biasotto M., Brai M., Misiano G., Meo T., and Tosi M. Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angioedema. Am J Hum Genet 59 (1996) 308-319
9. Cicardi M., Zingale L.C., Pappalardo E., Folcioni A., and Agostoni A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 82 (2003) 274-281
10. Caliezi C., Wuillemin W.A., Zeerleder S., Redondo M., Eisele B., and Hack C.E. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 52 (2000) 91-112
11. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 276 (2001) 33293-33296
12. Gaboriaud C., Thielens N.M., Gregory L.A., Rossi V., Fontecilla-Camps J.C., and Arlaud G.J. Structure and activation of the C1 complex of complement: unravelling the puzzle. Trends Immunol 25 (2004) 368-373
13. de Smet B.J., de Boer J.P., Agterberg J., Rigter G., Bleeker W.K., and Hack C.E. Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. Blood 81 (1993) 56-61
14. Blanch A., Roche O., Lopez-Granados E., Fontan G., and Lopez-Trascasa M. Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations. Hum Mutat 20 (2002) 405-406
15. Roche O., Blanch A., Duponchel C., Fontán G., Tosi M., and López-Trascasa M. Hereditary angioedema: The mutation spectrum of SERPING1/C1NH in a large Spanish cohort. Hum Mutat 26 (2005) 135-144
16. 443) in determination of target protease specificity. Inhibition of complement and contact system proteases. J Immunol 159 (1997) 983-988
17. Lacroix M.B., Aude C.A., Arlaud G.J., and Colomb M.G. Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r. Biochem J 257 (1989) 885-891
18. Tosi M. Molecular genetics of C1 inhibitor. Immunobiology 199 (1998) 358-365
19. Wright H.T., and Scarsdale J.N. Structural basis for serpin inhibitor activity. Proteins 22 (1995) 210-225
20. Bowen T., Cicardi M., Farkas H., Bork K., Kreuz W., Zingale L., et al. Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 114 (2004) 629-637